Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is receiving European Commission and French government funds to develop vaccines that prote… https://t.co/Ijt0cLCBd0
    about 9 hours ago
  • New post on Science and Enterprise: EC, France Fund Universal Covid-19, Flu Vaccines https://t.co/qT6cmb5P1S #Science #Business
    about 9 hours ago
  • Plant scientists in California discovered a natural peptide that stops bacteria from causing citrus greening, a dis… https://t.co/S4C9V2nW0p
    about 14 hours ago
  • New post on Science and Enterprise: Univ. Lab Discovers, Licenses Citrus Disease Treatment https://t.co/Hz2YkVgnac #Science #Business
    about 14 hours ago
  • The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines… https://t.co/7P1yBG9iO5
    about 1 day ago

Please share Science & Enterprise

Crispr Heart Therapy Demonstrated in Monkeys

Heart and major blood vessels

An experimental therapy using a precise gene editing technique is shown in lab monkeys to reverse the cause of a chronic form of heart disease. . . . → Read More: Crispr Heart Therapy Demonstrated in Monkeys

Convalescent Plasma Found Safe as Covid-19 Therapy

Blood plasma donation

Donated blood plasma from people who recovered from Covid-19 infections is found to cause few serious side effects when given as a treatment for infections in others. . . . → Read More: Convalescent Plasma Found Safe as Covid-19 Therapy

Crispr Heart Disease Start-Up Raises New $63M

Heart, circulation system

A one year-old company developing a one-time gene-editing treatment for coronary artery disease is adding $63 million to its first venture funding round. . . . → Read More: Crispr Heart Disease Start-Up Raises New $63M

Mayo Clinic, A.I. Company Study Covid-19 Heart Disease

Heart and major blood vessels

A developer of software to diagnose heart disease from images with artificial intelligence is assessing Covid-19 infection patients for heart ailments with the Mayo Clinic. . . . → Read More: Mayo Clinic, A.I. Company Study Covid-19 Heart Disease

Digital Health Research Platform Set for Covid-19

Stethoscope and iPhone

A group of medical technology companies are forming a research platform and registry for clinical trials of Covid-19 treatments among home-bound participants. . . . → Read More: Digital Health Research Platform Set for Covid-19

Wearable Defibrillator Maker Gains $145.6M

Heartbeat graphic

The developer of a patch device that monitors and adjusts heart rhythms to prevent sudden cardiac death is raising $145.6 million in a new venture funds. . . . → Read More: Wearable Defibrillator Maker Gains $145.6M

A.I. Heart Ultrasound Software Cleared by FDA

Caption Guidance screen

Software guided by algorithms that capture top-quality ultrasound images of the heart is now authorized by the Food and Drug Administration. . . . → Read More: A.I. Heart Ultrasound Software Cleared by FDA

Incubator Seeks Heart, Lung, Blood Device Entrepreneurs

Smartphones in business meeting

A business incubator in Massachusetts is seeking entrepreneurs and their companies developing medical devices for heart, lung, blood, and sleep disorders. . . . → Read More: Incubator Seeks Heart, Lung, Blood Device Entrepreneurs

Gene Therapy Licensed for Multiple Aging Diseases

Cavalier King Charles Spaniel

A university spin-off company developing treatments to extend the lifetimes of dogs is gaining a gene therapy for preventing multiple age-related diseases. . . . → Read More: Gene Therapy Licensed for Multiple Aging Diseases

FDA Clears A.I. Algorithms for Stethoscopes

Heart check

Algorithms used in analytical software for digital stethoscopes to diagnose irregular heart rhythms received marketing clearance from the U.S. Food and Drug Administration. . . . → Read More: FDA Clears A.I. Algorithms for Stethoscopes